LearnLaunch Accelerator Companies Collectively Raise More

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
55
LearnLaunch Accelerator Companies Collectively Raise More Than $10 Million in the First Quarter of 2017

BOSTON and AUSTIN, Texas, March 06, 2017 (GLOBE NEWSWIRE) -- LearnLaunch Accelerator, the leading startup program personalized for edtech entrepreneurs, announced today that six of its companies, active in the education technology sector, closed on funding in the first month of 2017. These six firms illustrate an increased early stage investment in education technology, an industry that facilitates learning and improving performance by creating, using and managing technology.

Edtech companies that raised Series A or seed stage investment include:

  • Metro DC-based Knowledge to Practice raised $6.5 million in its Series A round, led by ReThink Education.
  • Boston-based Authess raised a $2.2 million seed stage round led by EduLab.
  • Chalk Talk , based in Boston, closed on a $2.0 million Series A round led by angel investor Ibrahim Haddad.
  • Boston-based Kaymbu closed on a $1.5 million Series Seed round led by Reach Capital.
  • Riipen , headquartered in Vancouver, closed a $1.0 million Series Seed round led by angel investor Mohamed Mansour.
  • Pittsburgh-based Zulama closed the first $650,000 of a Series Seed round led by angel investor Jean Hammond.

“Education continues to change, and having six of our Accelerator companies reach these milestones in late 2016 and early 2017 is a reason for encouragement,” said Jean Hammond, LearnLaunch Co-Founder.

“LearnLaunch Accelerator companies are given a unique set of advantages,” said Liam Pisano, LearnLaunch Managing Director. “There are 35 edtech-focused companies housed on the LearnLaunch Campus, and we have more than 150 active mentors providing expertise and connections.  This edtech ecosystem supports entrepreneurs as they develop their business strategies, bringing value from day one of the LearnLaunch Accelerator program.”

Knowledge to Practice, an edtech market leader delivering competency based, personalized learning had the largest raise of LearnLaunch Accelerator participants.

"We knew our tailored continuing medical education products were uniquely meeting physicians' learning needs and preferences," said Mary Ellen Beliveau, M.Ed., CEO, Knowledge to Practice. "We decided to participate in LearnLaunch's Accelerator program to help us better define our go-to-market strategy. Broadening our GTM (go-to-market) strategy to include enterprise solutions enables us to leverage our data to serve critical needs of hospitals and healthcare systems.”

The LearnLaunch Accelerator portfolio houses diversified strategies that are front and center trends in edtech today, including augmented reality, machine learning, big data, and the like.

"There is broad consensus that we need to do a better job preparing learners and employees for success in a rapidly evolving workplace," noted Paul Crockett, CEO and co-founder of Authess. "Authess is using machine learning and data analytics for higher levels of assessment - to expose and measure the in-demand skills needed to thrive in today’s economy. This new funding allows us to accelerate development of our authoring framework and AI engine."

Furthermore, LearnLaunch Accelerator company CEOs are finding new ways to benefit from the evolution of education by exploring new revenue models, innovative offerings, and taking a fresh look at antiquated business models. 

“Schools traditionally teach to the curriculum, while test prep is typically offered by private tutors and after-school learning centers and only to those who can afford it,” said Chalk Talk founder and CEO Mohannad Arbaji. “Chalk Talk pioneered a new way to provide test prep that both improves student performance on their curriculum and increases standardized test scores at the same time . Using patent-pending technology, Chalk Talk's fully adaptive platform helps students achieve one of the highest average SAT, ACT, and SAT II score improvements on record. This new funding will increase our ability to reach more students across the globe.”

“We’re excited that 2017 is off to a great start for our companies.  While recent macro statistics point to a slowdown in early stage investment in the edtech space, we’re confident the LearnLaunch Accelerator process is effectively preparing our companies for a successful fundraise,” said Pisano. “It’s an important show of support by the edtech investment community, and validation of the value of LearnLaunch’s Accelerator program and strategy.”

About LearnLaunch Accelerator LearnLaunch Accelerator is the leading early stage edtech startup accelerator. LearnLaunch Accelerator provides the most promising education technology startups worldwide with up to $120,000 in seed funding, a personalized development plan, sector specific curriculum, and a network of industry focused mentors, intensive coaching and all the tools necessary to grow a successful edtech startup. It offers investors a diversified platform of early stage companies in the rapidly growing edtech sector. For more Information, visit www.learnlaunch.com/accelerator or follow us @LearnLaunchX.

About LearnLaunch LearnLaunch is dedicated to connecting, supporting, and investing in the education technology ecosystem to drive innovation and transform learning. It offers a vibrant community, educational events, a collaborative co-working space, and a selective accelerator program to promote the growth of the edtech sector. LearnLaunch is based in Boston, a global education hub. Learn more about LearnLaunch Accelerator, Campus, and Institute at www.learnlaunch.com and follow LearnLaunch on Twitter at @learnlaunch.

CONTACT: Josef Blumenfeld EdTech180 for LearnLaunch 508.333.0938 Joe@EdTech180.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles